PCOS患者IVF/ICSI时应用GnRH-a长方案与拮抗剂方案累积活产率的比较(4)
[7]Trenkic M，Popovic)，Kopitovic V，Bjelica A，ZivadinovicR，Pop-Trajkovic S.Flexible GnRH antagonist protocol vs.longGnRH agonist protocol in patients with polycystic ovary syndrometreated for IVF：comparison of clinical outcome and embryoquality.Ginekol Pol，2016，87(4)：265-270.
[8]Lambalk CB，Banga FR，Huirne JA，Toftager M，Pinborg A，Homburg R，van der Veen F，van Wely M.GnRH antagonistversus long agonist protocols in IVF：a systematic review andmeta-analysis accounting for patient type.Hum Reprod Update，2017，23(5)：560-579.
, 百拇医药
[9]Onofriescu A，Bors A，Luca A，Holicov M，Onofriescu M，Vul-poi C.GnRH antagonist IVF protocol in PCOS.Cuff Health Sci J，2013，39(1)：20-25.
[10]Kim CH，Moon JW，Kang HJ，Ahn JW，Kim SH，Chae HD，Kang BM.Effectiveness of GnRH antagonist multiple doseprotocol applied during early and late follicular phase comparedwith GnRH agonist long protocol in non-obese and obese patientswith polycystic ovary syndrome undergoing IVF/ICSI.Clin ExpReprod Med，2012，39(1)：22-27.
, 百拇医药
[11]Toftager M，Sylvest R，Schmidt L，Bogstad J，Lessl K，Praetorius L，Zedeler A，Bryndorf T，Pinborg A.Quality of lifeand psychosocial and physical well-being among 1，023 womenduring their first assisted reproductive technology treatment：secondary outcome to a randomized controlled trial comparinggonadotropin-releasing hormone(GnRH)antagonist and CnRHagonist protocols.Fertil Steril，2018，109(1)：154-164.
[12]Kasum M，Oreskovic S，Franulic D，Cehic E，Lila A，Vujic G，Grgic F.Current medical strategies in the prevention of ovarianhyperstimulation syndrome.Acta Clin Croat，2017，56(1)：133-142.
, 百拇医药
[13]Orvieto R，Rabinson J，Meltzer S，Homburg R，Anteby E，Zohav E.GnRH agonist versus GnRH antagonist in ovarian stim-ulation：is the emperor naked？ Clin Exp Obstet Gynecol，2006，33(4)：197-199.
[14]Orvieto R，Meltzer S，Rabinson J，Zohav E，Anteby EY，Nahum R.GnRH agonist versus CnRH antagonist in ovarian stimulation：the role of endometrial receptivity.Fertil Steril，2008，90(4)：1294-1296.
[15]Toftager M，Rogstad J，Lessl K，Praetorius L，Zedeler A，Bry-ndorf T，Nilas L，Pinborg A.Cumulative live birth rates afterone ART cycle including all subsequent frozen-thaw cycles in1050 women：secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.Hum Reprod，2017，32(3)：556-567.
[16]Wang R，Lin S，Wang Y，Qian W，Zhou L.Comparisons ofGnRH antagonist protocol versus GnRH agonist long protocol inpatients with normal ovarian reserve：a systematic review andmeta-analysis.PLoS One，2017，12(4)：e0175985., 百拇医药(郭希 陈明晖 乌日汗 沈晓婷 刘洋 钟依平)
[8]Lambalk CB，Banga FR，Huirne JA，Toftager M，Pinborg A，Homburg R，van der Veen F，van Wely M.GnRH antagonistversus long agonist protocols in IVF：a systematic review andmeta-analysis accounting for patient type.Hum Reprod Update，2017，23(5)：560-579.
, 百拇医药
[9]Onofriescu A，Bors A，Luca A，Holicov M，Onofriescu M，Vul-poi C.GnRH antagonist IVF protocol in PCOS.Cuff Health Sci J，2013，39(1)：20-25.
[10]Kim CH，Moon JW，Kang HJ，Ahn JW，Kim SH，Chae HD，Kang BM.Effectiveness of GnRH antagonist multiple doseprotocol applied during early and late follicular phase comparedwith GnRH agonist long protocol in non-obese and obese patientswith polycystic ovary syndrome undergoing IVF/ICSI.Clin ExpReprod Med，2012，39(1)：22-27.
, 百拇医药
[11]Toftager M，Sylvest R，Schmidt L，Bogstad J，Lessl K，Praetorius L，Zedeler A，Bryndorf T，Pinborg A.Quality of lifeand psychosocial and physical well-being among 1，023 womenduring their first assisted reproductive technology treatment：secondary outcome to a randomized controlled trial comparinggonadotropin-releasing hormone(GnRH)antagonist and CnRHagonist protocols.Fertil Steril，2018，109(1)：154-164.
[12]Kasum M，Oreskovic S，Franulic D，Cehic E，Lila A，Vujic G，Grgic F.Current medical strategies in the prevention of ovarianhyperstimulation syndrome.Acta Clin Croat，2017，56(1)：133-142.
, 百拇医药
[13]Orvieto R，Rabinson J，Meltzer S，Homburg R，Anteby E，Zohav E.GnRH agonist versus GnRH antagonist in ovarian stim-ulation：is the emperor naked？ Clin Exp Obstet Gynecol，2006，33(4)：197-199.
[14]Orvieto R，Meltzer S，Rabinson J，Zohav E，Anteby EY，Nahum R.GnRH agonist versus CnRH antagonist in ovarian stimulation：the role of endometrial receptivity.Fertil Steril，2008，90(4)：1294-1296.
[15]Toftager M，Rogstad J，Lessl K，Praetorius L，Zedeler A，Bry-ndorf T，Nilas L，Pinborg A.Cumulative live birth rates afterone ART cycle including all subsequent frozen-thaw cycles in1050 women：secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.Hum Reprod，2017，32(3)：556-567.
[16]Wang R，Lin S，Wang Y，Qian W，Zhou L.Comparisons ofGnRH antagonist protocol versus GnRH agonist long protocol inpatients with normal ovarian reserve：a systematic review andmeta-analysis.PLoS One，2017，12(4)：e0175985., 百拇医药(郭希 陈明晖 乌日汗 沈晓婷 刘洋 钟依平)